Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas

Phase 1

Terminated

Conditions: Relapsed Lymphomas
Refractory Lymphomas

Interventions: Drug: Vorinostat
Drug: Pegylated Liposomal Doxorubicin (PLD), Doxil

First Posted Date: 2008-11-05

Last Posted Date: 2022-04-04

Lead Sponsor: Yale University

Target Recruit Count: 17

Registration Number: NCT00785798

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Examining New Diagnostic Tests for Acute Kidney Injury After Heart Surgery

Completed

Conditions: Renal Insufficiency
Kidney Failure, Acute

First Posted Date: 2008-10-17

Last Posted Date: 2020-04-03

Lead Sponsor: Yale University

Target Recruit Count: 1550

Registration Number: NCT00774137

Locations: 🇺🇸
University of Colorado Health Sciences Center, Denver, Colorado, United States
🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
🇺🇸
Danbury Hospital, Danbury, Connecticut, United States

and more 5 locations

Modeling Stress-precipitated Smoking Behavior for Medication Development

Phase 2

Completed

Conditions: Smoking

Interventions: Drug: guanfacine
Drug: placebo

First Posted Date: 2008-10-16

Last Posted Date: 2022-08-03

Lead Sponsor: Yale University

Target Recruit Count: 100

Registration Number: NCT00773357

Locations: 🇺🇸
Yale Center for Clinical Investigation, Yale University, New Haven, Connecticut, United States

The Effect of Naltrexone and Varenicline on Alcohol-Mediated Smoking Lapse

Phase 2

Completed

Conditions: Smoking

Interventions: Drug: placebo
Drug: naltrexone
Drug: varenicline

First Posted Date: 2008-10-16

Last Posted Date: 2018-04-23

Lead Sponsor: Yale University

Target Recruit Count: 30

Registration Number: NCT00773422

Locations: 🇺🇸
Yale Center for Clinical Investigation, Yale University, New Haven, Connecticut, United States

Detection of Ischemia in Asymptomatic Diabetics

Completed

Conditions: Type 2 Diabetes Mellitus

First Posted Date: 2008-10-09

Last Posted Date: 2008-10-09

Lead Sponsor: Yale University

Target Recruit Count: 1123

Registration Number: NCT00769275

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Microsurgical Varicocelectomy Versus No Surgery in Men With a Palpable Varicocele and an Abnormal Semen Analysis

Phase 3

Terminated

Conditions: Pregnancy
Infertility

Interventions: Behavioral: Timed intercourse
Procedure: Microsurgical varicocelectomy
Procedure: Intrauterine insemination

First Posted Date: 2008-10-07

Last Posted Date: 2013-07-02

Lead Sponsor: Yale University

Target Recruit Count: 3

Registration Number: NCT00767338

Locations: 🇺🇸
University of Medicine and Dentistry of New Jersey, Newark, New Jersey, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
University of Vermont, Burlington, Vermont, United States

and more 6 locations

Effects of Paliperidone in Posttraumatic Stress Disorder (PTSD)

Phase 4

Withdrawn

Conditions: Posttraumatic Stress Disorder

Interventions: Drug: Paliperidone

First Posted Date: 2008-10-03

Last Posted Date: 2016-08-23

Lead Sponsor: Yale University

Registration Number: NCT00766064

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

Cortical GABA Concentrations in Insomnia

Completed

Conditions: Insomnia
Major Depression

First Posted Date: 2008-10-03

Last Posted Date: 2013-01-21

Lead Sponsor: Yale University

Target Recruit Count: 23

Registration Number: NCT00765752

Locations: 🇺🇸
Yale Depression Research Program, New Haven, Connecticut, United States

Effects of Duloxetine on Fear Conditioning in Posttraumatic Stress Disorder (PTSD)

Early Phase 1

Completed

Conditions: Posttraumatic Stress Disorder

Interventions: Drug: Duloxetine

First Posted Date: 2008-09-30

Last Posted Date: 2015-04-23

Lead Sponsor: Yale University

Target Recruit Count: 26

Registration Number: NCT00763178

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

Domperidone in Refractory Gastroparesis

Phase 2

Terminated

Conditions: Gastroparesis

Interventions: Drug: Domperidone

First Posted Date: 2008-09-26

Last Posted Date: 2017-08-18

Lead Sponsor: Yale University

Target Recruit Count: 44

Registration Number: NCT00760461

Locations: 🇺🇸
Yale Digestive Diseases 40 Temple St, Suite 1A, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy